Cargando…
Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro
The Middle East respiratory syndrome-coronavirus (MERS-CoV), first identified in Saudi Arabia, is an emerging zoonotic pathogen that causes severe acute respiratory illness in humans with a high fatality rate. Since its emergence, MERS-CoV continues to spread to countries outside of the Arabian Peni...
Autores principales: | Shin, Jin Soo, Jung, Eunhye, Kim, Meehyein, Baric, Ralph S., Go, Yun Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6024778/ https://www.ncbi.nlm.nih.gov/pubmed/29795047 http://dx.doi.org/10.3390/v10060283 |
Ejemplares similares
-
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL(Pro) inhibitors
por: Kumar, Vathan, et al.
Publicado: (2017) -
Infection, Replication, and Transmission of Middle East Respiratory Syndrome Coronavirus in Alpacas
por: Adney, Danielle R., et al.
Publicado: (2016) -
Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation
por: Thornbrough, Joshua M., et al.
Publicado: (2016) -
The influence of interferon-lambda on restricting Middle East Respiratory Syndrome Coronavirus replication in the respiratory epithelium
por: Jeon, Yung Jin, et al.
Publicado: (2020) -
Replicative virus shedding in the respiratory tract of patients with Middle East respiratory syndrome coronavirus infection
por: Park, Wan Beom, et al.
Publicado: (2018)